Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

By afschroeder • August 29, 2026

Masri A, Maron MS, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Barriales-Villa R, Choudhury L, Claggett BL, Coats CJ, Correia EB, Costabel JP, Elliott PM, Silva Enciso JE, Garcia-Pavia P, Ge J, Hegde SM, Lewis GD, Lopes RD, Martinez MW, Maurer MS, Miao ZM, Michels M, Mitter SS, Pino Moreno JE, Olivotto I, Owens AT, Poulsen SH, Rader F, Rowin EJ, Schulze PC, Sepp R, Sikand N, Solomon SD, Spertus JA, Teale C Sr, Zhao X, Divanji PH, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Salazar-Mendiguchía J, Wohltman A, Zhuo S, Ho CY; ACACIA-HCM Investigators. Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2026 Aug 28. doi: 10.1056/NEJMoa2603021. Epub ahead of print. PMID: 42663312.

Tags: Cardiology/Epi, Cedars Sinai DoM, Publications

2026 SNMMI Highlights Lecture: Cardiovascular Sciences

Packard RRS. 2026 SNMMI Highlights Lecture: Cardiovascular Sciences. J Nucl Med. 2026 Nov 2;67(11):1705-1710. doi: 10.2967/jnumed.126.273334. PMID: 42595492.

Validation of the PREVENT-HF Risk Prediction Equation in US Veterans

Tisdale RL, Kalwani NM, Fan J, McDonald V, Shalen EF, Chan B, Verma A, Din N, Sahay A, Ambrosy AP, Heidenreich P, Sandhu AT. Validation[...]

Pseudo-Conduction After Cavotricuspid Isthmus Ablation: Insights From High-Density Mapping

Shen Y, Mori S, Xue X, Liu H, Chen M. Pseudo-Conduction After Cavotricuspid Isthmus Ablation: Insights From High-Density Mapping. JACC Case Rep. 2026 Nov 2:111015.[...]